8-K: Cyabra Receives Nasdaq Delisting Deficiency Notices

Cyabra, Inc. has been notified by Nasdaq of non-compliance with minimum market value and bid price listing requirements.

Summary

• Cyabra, Inc. received formal notification from Nasdaq on June 9, 2026, regarding non-compliance with two listing standards.
• The company failed to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 for 30 consecutive business days.
• The company failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days.
• The company has until December 7, 2026, to regain compliance with both requirements.
• The company's common stock continues to trade under the symbol CYAB without immediate impact.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development, as it highlights significant downward pressure on the company's valuation and potential long-term listing risks.

Positives

• The company has a 180-day grace period to rectify the deficiencies, providing time to implement corrective measures.
• The notification does not result in an immediate suspension or delisting of the company's common stock.

Negatives

• Failure to meet Nasdaq's minimum bid price requirement of $1.00 per share.
• Failure to meet Nasdaq's minimum Market Value of Publicly Held Shares requirement of $15,000,000.
• Increased regulatory scrutiny and potential risk of future delisting if compliance is not restored.

Risks

• Risk of delisting from The Nasdaq Stock Market if compliance is not regained by December 7, 2026.
• Potential negative impact on stock liquidity and investor perception due to the deficiency notices.
• No assurance that the company will be able to regain compliance within the prescribed timeframes.

Future Outlook

The company intends to monitor its stock performance and explore options to regain compliance, though it acknowledges there is no guarantee that it will successfully meet the requirements within the 180-day period.

Management Comments

• The company is working diligently to regain compliance with Nasdaq's listing rules.

Industry Context

StockSavvy.ai notes that receiving deficiency notices is a common challenge for small-cap and growth-stage companies during periods of market volatility, often necessitating strategic actions such as reverse stock splits or capital raises to boost valuation metrics.

Comparison to Industry Standards

• Nasdaq listing standards are stringent, and failure to maintain these levels is a significant indicator of underperformance relative to broader market indices.
• Many growth-stage companies in the technology sector face similar pressures when market sentiment shifts, often leading to increased volatility in share price.

Stakeholder Impact

• Shareholders may experience increased volatility and uncertainty regarding the stock's listing status.
• Potential impact on the company's ability to raise capital or attract institutional investors while in non-compliance.

Next Steps

• Monitor the closing bid price of common stock.
• Evaluate potential strategies to increase market value and share price.
• Prepare for potential appeal or transfer to the Capital Market if compliance is not met by December 7, 2026.

Key Dates

Recommendation

The receipt of dual deficiency notices from Nasdaq indicates significant financial and market-based challenges, suggesting a high risk of further downside or potential delisting, which warrants a cautious or defensive stance.

Keywords

Nasdaq, Delisting, Compliance, CYAB, Market Value, Bid Price, Cyabra